Tuesday, November 24, 2009

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
New RA drug meets goals in new trial

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

New RA drug meets goals in new trial

(Reuters) UPDATED 2009-10-17

A drug being developed to treat rheumatoid arthritis (RA) was found to work at treating the condition in a new trial. The med, currently known as CP-690,550,, was effective as both a stand-alone treatment and as a combination therapy with methotrexate, the standard therapy for the disease, scientists say. The drug is one of new class of drugs known as oral JAK inhibitors, which are being tested for their effects on enzymes linked to inflammatory and autoimmune diseases. Read full story >

See all Rheumatoid Arthritis News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.